The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells

ABSTRACT Recently a cell culture model supporting the complete life cycle of the hepatitis C virus (HCV) was developed. Searching for host cell determinants involved in the HCV replication cycle, we evaluated the efficiency of virus propagation in different Huh-7-derived cell clones. We found that Huh-7.5 cells and Huh7-Lunet cells, two former replicon cell clones that had been generated by removal of an HCV replicon by inhibitor treatment, supported comparable levels of RNA replication and particle production, whereas virus spread was severely impaired in the latter cells. Analysis of cell surface expression of CD81 and scavenger receptor class B type I (SR-BI), two molecules previously implicated in HCV entry, revealed similar expression levels for SR-BI, while CD81 surface expression was much higher on Huh-7.5 cells than on Huh7-Lunet cells. Ectopic expression of CD81 in Huh7-Lunet cells conferred permissiveness for HCV infection to a level comparable to that for Huh-7.5 cells. Modulation of CD81 cell surface density in Huh-7.5 cells by RNA interference indicated that a certain amount of this molecule (∼7 × 104 molecules per cell) is required for productive infection with a low dose of HCV. Consistent with this, we show that susceptibility to HCV infection depends on a critical quantity of CD81 molecules. While infection is restricted in cells expressing very small amounts of CD81, susceptibility rapidly rises within a narrow range of CD81 levels, reaching a plateau where higher expression does not further increase the efficiency of infection. Together these data indicate that a high density of cell surface-exposed CD81 is a key determinant for productive HCV entry into host cells.

[1]  Ralf Bartenschlager,et al.  Novel insights into hepatitis C virus replication and persistence. , 2004, Advances in virus research.

[2]  G. Thomson A direct deduction of the constant process used in the method of right and wrong cases. , 1919 .

[3]  Ralf Bartenschlager,et al.  Kissing-Loop Interaction in the 3′ End of the Hepatitis C Virus Genome Essential for RNA Replication , 2005, Journal of Virology.

[4]  Robert J. Linhardt,et al.  Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate* , 2003, Journal of Biological Chemistry.

[5]  L. Seeff Natural history of chronic hepatitis C , 2002 .

[6]  B. Williams,et al.  Replication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon Activities , 2006, Journal of Virology.

[7]  Christopher T. Jones,et al.  University of Birmingham Time-and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry , 2006 .

[8]  R. Bartenschlager,et al.  Dissecting the Interferon-Induced Inhibition of Hepatitis C Virus Replication by Using a Novel Host Cell Line , 2005, Journal of Virology.

[9]  A. Moorman,et al.  Electrotransfection with "intracellular" buffer. , 1995, Methods in molecular biology.

[10]  Toshiaki Maruyama,et al.  Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.

[11]  C. Rice,et al.  Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Voisset,et al.  Hepatitis C virus entry: potential receptors and their biological functions. , 2006, The Journal of general virology.

[13]  William M. Lee,et al.  Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Lemon,et al.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Mizokami,et al.  Genotype 2a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG2 and IMY-N9 Cells* , 2004, Journal of Biological Chemistry.

[16]  C. Spearman,et al.  The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulae , 1908 .

[17]  D. Burton,et al.  Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Kingsman,et al.  A transient three-plasmid expression system for the production of high titer retroviral vectors. , 1995, Nucleic acids research.

[19]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[20]  Charles M. Rice,et al.  Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication , 2002, Journal of Virology.

[21]  L. Seeff,et al.  Natural history of chronic hepatitis C , 2002, Hepatology.

[22]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[23]  R. Bartenschlager,et al.  Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses , 2006, Journal of Virology.

[24]  R. Bartenschlager,et al.  Efficient hepatitis C virus cell culture system: what a difference the host cell makes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Seeger,et al.  Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells , 2003, Journal of Virology.

[26]  Ralf Bartenschlager,et al.  Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture , 2003, Journal of Virology.

[27]  D. Lamarre,et al.  Hepatitis C Virus Subgenomic Replicons in the Human Embryonic Kidney 293 Cell Line , 2004, Journal of Virology.

[28]  L. Cosmi,et al.  Binding of Hepatitis C Virus Envelope Protein E2 to CD81 Up-regulates Matrix Metalloproteinase-2 in Human Hepatic Stellate Cells* , 2005, Journal of Biological Chemistry.

[29]  C. Rice,et al.  CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection , 2004, Journal of Virology.

[30]  Takeharu Nagai,et al.  Shift anticipated in DNA microarray market , 2002, Nature Biotechnology.

[31]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[32]  J. Hoofnagle Course and outcome of hepatitis C , 2002 .

[33]  B. Bartosch,et al.  Cell entry of hepatitis C virus. , 2006, Virology.

[34]  J. Hoofnagle Course and outcome of hepatitis C , 2002, Hepatology.

[35]  S. Lemon,et al.  Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I , 2005, Journal of Virology.

[36]  D. Rowe,et al.  Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. , 2001, Virology.

[37]  T. Dragic,et al.  CD81 is an entry coreceptor for hepatitis C virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Christophe Combet,et al.  Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes , 2005, Hepatology.

[39]  E. Blanchard,et al.  Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis , 2006, Journal of Virology.

[40]  Ralf Bartenschlager,et al.  Alternative Approaches for Efficient Inhibition of Hepatitis C Virus RNA Replication by Small Interfering RNAs , 2004, Journal of Virology.

[41]  G. Kärber,et al.  Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche , 1931, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.

[42]  A. Shavinskaya,et al.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. , 2006, Proceedings of the National Academy of Sciences of the United States of America.